Article
Evaluation of turnaround times and performance of in-house ChromaCode high-definition PCR compared to send-out next-generation sequencing in non-small cell lung cancer.
American journal of clinical pathology - 26 Aug 2025
Hogarth Nathan C, Al-Kawaaz Mustafa, Linder Mark W
Abstract excerpt
OBJECTIVE: Lung cancer is the leading cause of cancer deaths globally, with 1.8 million deaths annually. Advances in targeted therapy and molecular testing for key mutations in non-small cell lung cancer (NSCLC) have improved survival rates. The benchmark turnaround time for molecular testing is 10 days; however, send-out next-generation sequencing (NGS) can often take 14 to 28 days. METHODS: The ChromaCode NSCLC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
